Member Info for Richard08

For 'sad old git view' I read 'life experience' and 'probably right'!

Of course, time will tell, but it won't be the first time something like this has happened.

That January spike was down to a mention on a popular youtuber's video and everyone jumped on board for a brief period. Hopefully though it'll be a genuine rise in 2022!

Should have said 'company' rather than 'country' in the opening line! That's what comes of listening to the news at the same time as typing. Mind you, I would rather have Danny and David running the country than Boris but that's a whole different conversation...!

I firmly believe the new management are quietly running the country in the background and will update us in due course. A trading update is due at the end of January or beginning of February based on historical updates but beyond that I don't think we'll see anything. This is just my opinion, but one of my few abilities is that I'm a good judge of character, and both Danny and David come across as the cerebral, quietly confident types who know what they are doing and will run this company well. They won't be a hostage to the share price and announce something whenever it falls an amount we think is 'a lot' as that way madness lies. The trading update due only runs to the end of December and up to that point, as far as we can tell, surgery in the US has been running at slightly below capacity. Looking at the Q3 results from Smith and Nephew they experienced some issues in the US due to a reduction in surgery but nothing massive. I expect similar from TRX. The company is in a much stronger position now and the question of when will it break even is now a question of 'when' not 'if'. The pandemic may delay this but I would still expect it this year or next depending on how this winter plays out with Omicron. Then it's just a question of building the profile of the company and selling it's products which has never been a problem. And then we can start to think about expansion plans etc. I know it's commonly said with shares/companies that 'this year will be different' but with TRX, finally, it should be true!

Happy New Year PXC investors, question about funding for Empire, have we got the $52 million to fund the mine yet? I haven’t seen an RNS and I know they were going for debt to fund it. Any thoughts gratefully received.

Bet he wishes he’d bought the day before! Good to see though.

Couldn’t agree more Twohits. Where M&G lead others may follow. They have their own version of FOMO and no fund manager wants to face their own board/investors in five plus years and be asked ‘Why didn’t you buy a slice of that?’ By the same token, M&G will be in it for the long haul, they’re not interested in a quick profit and they must have been watching for a while and decided this is a good price to buy in. Will be interesting to see who comes next!

p.s. TRX doesn’t always move this much in a day. Sometimes it’s even more! Brace yourself.

Morning ROCKETVI, welcome to the club!

Various bits of research below for you to peruse. Hope it's of use:

Hear what Gervaise Williams of Premier Miton has to say about the company
https://www.youtube.com/watch?v=6QdeB9B8mtE

Hardman reports
https://www.hardmanandco.com/research/
Hardman report author gives more background on company
https://vimeo.com/572960828

See news on Proactive for media updates
https://www.proactiveinvestors.co.uk/companies/news/904109/tissue-regenix-ready-to-build-on-strong-performance-through-pandemic-904109.html

Search on ‘linkedin’ for ‘Tissue Regenix’ for regular case studies by surgeons using TRX’s products and their feedback.

I can sympathise Sbuild, I was fortunate to come across this company more recently so am only slightly underwater. I would point towards today's RNS showing that they are delivering. I think the last two years have been extraordinarily tough for small companies and for them to achieve these deliveries is a credit to them. Certainly they have sold more shares at ever increasing prices and the inevitable dilution but they are delivering their product in multiple countries to several different types of customer which to me underlines it's appeal and utility in a wide range of applications. I do still think this is a two year investment (wait until the Gamesa deal comes through) and see what happens post pandemic. I do feel your pain though, I am currently saying good bye to certain underperforming so-called 'growth' stocks that seem to be doing a Benjamin Button but Invinity is not one of them!

The next announcement from the company will probably be the Feb trading update, unless there is significant news before then e.g. new product lines. The Feb update will be the period up until 31st December and at the moment surgery rates are running more or less as normal in the US and have been throughout the summer and autumn. Therefore there is every reason to be confident in the next results. The first quarter of 2022 will probably be poorer due to the winter covid increase but I doubt there will be the same level of elective surgery suspension as there was last year. This will also be balanced out by the rest of 2022 when the boosters have been fully rolled out and IF the current projections bear out for covid becoming endemic and seasonal rather than maintaining its current pandemic status life should return to normal (ish!)

In summary, TRX should be ok! I say this from a position of being slightly underwater too but with every intention of buying more if the sp dips further.

Interesting to see Amati taking a 5% stake. Interesting and encouraging! See their website for details but their fund of AIM companies has outperformed the market for some time. Hopefully they’ve picked a winner here too!

Ah if only Phimx. Right now though, Boris is trying to pretend he didn’t know a party was going on in the building where he lives whilst attempting to bury the news under a press conference.

And given that sales were sustained over 2020-1 with a small increase in overall profit shows that TRX can weather the storm. This winter will be nowhere near as bad as last for operations etc. So TRX's sales should be better than last year and I'm confident in the new management team. Smith and Nephew and Intuitive Surgical all operate in the US and report quarterly. They show a mixed picture for Q3 2021 but generally an upward path for number of operations.

the whole sector has been suffering recently but especially today. In tonight's LSE email you may have seen the following already:

Cellular Goods (CBX) 6.85 -5.52%
Verici Dx (VRCI) 52.50 -5.41%
Anpario (ANP) 675.00 -4.93%
Gunsynd (GUN) 0.975 -4.88%
N4 Pharma Plc (N4P) 7.80 -4.29%

so although it's not great the sp is falling it's most certainly not company specific. Could be a bit of manipulation but i think negative-covid sentiment has crept into the sector and has yet to be lifted.

ditto to that Extasio. A routine mining problem that isn't management's fault. It's already been rectified and as usual the market has over reacted. A short term problem creating a buying opportunity.

I think the main point in Invinity’s favour is that their technology is out there working in the real world and potential buyers can see that. Watch the most recent presentation on the website for more info. They do have a growing order book and have accomplished a lot whilst dealing with the problems of COVID. DYOR of course though!

I don't know much about largo but Bushveld is an expanding vanadium miner whose price is tied to the vanadium price and is suffering at the moment as the V price is falling. FAR is also stealing some of the limelight as the new kid on the block promising cheaper costs. I'm quite a fan of Invinity (disclaimer!) but they do seem to be in a strong position so far as technology and management are concerned and are getting their product out there along with impressing big boys such as Siemens gamesa. They are struggling to make money though and keep needing fund raising. It there fore classes as a risky speculation. But they founded the company during a pandemic, established deals during lockdowns and expanded production and distribution during sky rocketing shipping costs so if they don't execute it won't be down to management failing. However, do your own research and good luck.

My favourite bit is when Larry says 'lithium systems only occasionally catch fire'!! There's a strap line Tesla haven't considered!

Thanks for this superzero8. A bit of light listening to calm me down after a rough day watching my portfolio!! Have you had your msg about the rights issue by the way? As the current sp is below the £1 they are offering I won't be taking part! But hoping the sp will go up once the offering is over and the shares are admitted. That's what usually seems to happen. Although we live in interesting times...